AKERO Trademark

Trademark Overview

On Wednesday, August 22, 2018, a trademark application was filed for AKERO with the United States Patent and Trademark Office. The USPTO has given the AKERO trademark a serial number of 88979629. The federal status of this trademark filing is REGISTERED as of Tuesday, December 22, 2020. This trademark is owned by Akero Therapeutics, Inc.. The AKERO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals; clinical research in the field of pharmaceuticals

General Information

Serial Number88979629
Word MarkAKERO
Filing DateWednesday, August 22, 2018
Status700 - REGISTERED
Status DateTuesday, December 22, 2020
Registration Number6228033
Registration DateTuesday, December 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2019

Trademark Statements

Goods and ServicesResearch and development of pharmaceuticals; clinical research in the field of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 30, 2018
Primary Code042
First Use Anywhere DateMonday, June 25, 2018
First Use In Commerce DateSaturday, June 30, 2018

Trademark Owner History

Party NameAkero Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAkero Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameAkero Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Saturday, August 25, 2018NEW APPLICATION ENTERED
Thursday, August 30, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 7, 2018ASSIGNED TO EXAMINER
Thursday, December 13, 2018PRIORITY ACTION WRITTEN
Thursday, December 13, 2018PRIORITY ACTION E-MAILED
Thursday, December 13, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, June 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 2, 2019ASSIGNED TO LIE
Wednesday, July 17, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2019PUBLISHED FOR OPPOSITION
Tuesday, August 6, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 19, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, March 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 26, 2020SOU TEAS EXTENSION RECEIVED
Thursday, March 26, 2020SOU EXTENSION 1 FILED
Thursday, March 26, 2020SOU EXTENSION 1 GRANTED
Saturday, March 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 28, 2020TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 5, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 19, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 28, 2020DIVISIONAL REQUEST RECEIVED
Thursday, November 19, 2020DIVISIONAL PROCESSING COMPLETE
Monday, September 28, 2020NOTICE OF ALLOWANCE CANCELLED
Thursday, November 19, 20201(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, December 22, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, December 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 7, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 7, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 22, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

akero research pharmaceuticals field clinical development